Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersCalendar 

Johnson & Johnson Innovation Announces Collaborations with Two Canadian Early-Stage Drug Technology Development Centers

12/10/2013 | 08:09am US/Eastern

Johnson & Johnson Innovation and its affiliate Janssen Inc. in Canada today announced new collaborations with two Canadian early-stage drug technology development centers, Montreal-based NEOMED and Toronto-based MaRS Innovation, to identify and advance promising bio/pharmaceutical technologies that have the potential to impact human health.

Through these collaborations, technical experts from the Johnson & Johnson Innovation Center in Boston, Massachusetts will work with NEOMED and MaRS Innovation to identify investment opportunities emerging from well-validated scientific research discoveries within their communities of academic institutions and biotechnology companies.

"We know from our history of engagement that the Canadian bio/pharmaceutical environment is one of the most vibrant in the world," said Robert Urban, Head of the Johnson & Johnson Innovation Center, Boston. "These new collaborations will allow us to potentially advance important new clinical candidates against disease."

"Quebec and Ontario are home to numerous world-class academic and biomedical research enterprises," said Paul Kershaw, Vice President of Medical Affairs, Janssen Inc. in Canada. "These new relationships with NEOMED and MaRS Innovation are an extension of our commitment to Canada's innovative research community."

NEOMED is a not-for-profit, public-private Pharma alliance dedicated to drug discovery and development. Partially funded by the Ministère des Finances et de l'Économie du Québec, NEOMED is within the NEOMED Institute, a state-of-the-art R&D facility in the Montréal Technoparc.

MaRS Innovation is the commercialization agent for Ontario's discovery pipeline from 16 leading academic institutions. MaRS Innovation is supported by the Government of Canada through the Networks of Centres of Excellence, by the Government of Ontario through the Ontario Centres of Excellence, and by its 16 member institutions.

About Johnson & Johnson Innovation

The Boston Innovation Center is part of Johnson & Johnson Innovation, a division of Johnson & Johnson Finance Corporation. Johnson & Johnson Innovation focuses on accelerating early innovation and enhancing opportunities for collaboration and investment across Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies focused on early-stage opportunities a one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and diagnostics and consumer companies of Johnson & Johnson. Johnson & Johnson Innovation includes local deal-making capabilities with the flexibility to adapt deal structures to match early-stage opportunities and establish novel collaborations that speed development of those innovations to solve unmet needs in patients. Follow us @jnjinnovation on Twitter. Please visit www.jnjinnovation.com for more information.

About Janssen Inc.

Janssen is dedicated to addressing and solving some of the most important unmet medical needs of our time in oncology, immunology, neuroscience, infectious diseases and vaccines, metabolic and chronic diseases and women's health. Driven by our commitment to patients, we bring innovative products, services and solutions to people throughout the world. Janssen Inc. in Canada is part of the Janssen Pharmaceutical Companies of Johnson & Johnson. Please visit http://www.janssen.ca for more information.

Johnson & Johnson
John Lacey, 781-392-5514
jlacey1@ITS.JNJ.com
or
Feinstein Kean Healthcare
Jessica Rowlands, 202-729-4089
jessica.rowlands@fkhealth.com


© Business Wire 2013
React to this article
Latest news
Date Title
02:27p LONZA : Pease Lonza may add up to 400 jobs Firm requests city cut building permit fees
02:24p INPLAY PRODUCTS : ' KOOBA Announces New Distribution Deal
02:18p WINN DIXIE STORES : Marathon McDonald's might be getting a second drive-through
02:18pDJHellfire Missile Mistakenly Sent to Cuba Has Been Returned to U.S.
02:08p SPECTRUM BRANDS : names new exec chairman, with high level pay package
02:05p NISSAN MOTOR : 1 dead in Indiana Toll Road crash
02:05p UNIC TECHNOLOGY : World Radio Day marked
02:04p ROYAL DUTCH SHELL A : Nobel Upstream acquires Shells stake in North Seas Maclure field
02:04p ROYAL DUTCH SHELL A : Low oil prices cast doubt on Mozambiques Gas Master Plan
02:04p ARALEZ PHARMACEUTICALS INC. (NASDAQ : ARLZ) to Ring The Nasdaq Stock Market Closing Bell
Latest news
Advertisement
Hot News 
AVENIR TELECOM : CSU textiles, design museum opens four exhibits to mark major expansion
VENTURE LIFE : In GBP3.7 Million Fundraising To Buy Mouthwash Maker (ALLISS)
DEUTSCHE POSTBANK : self-service solutions put control in customers' hands
LONDON & ASSOCIATED PROPERTIES : AND ASSOCIATED PROPERTIES PLC - Director/PDMR Shareholding
Paragon Offshore to File for Bankruptcy
Most Read News
08:33a Israeli CyberArk releases bombastic 2015 earnings report
03:27a RBS hatches new businesses at HQ
02/12 PGA TOUR : Palmer's ace a winner for lucky fan
02/12 THE FEMALE HEALTH COMPANY : Supports UNAIDS’ Call for Increased Investments in Condoms
02/12 CALIFORNIA AIR RESOURCES BOARD : ARB Newsclips for February 12, 2016.
Most recommended articles
02:18pDJHellfire Missile Mistakenly Sent to Cuba Has Been Returned to U.S.
01:10p Greek PM says differences between lenders delaying bailout review - paper
12:45p Slovak PM says negative bond yields should spur borrowing
11:39aDJBAE Systems Poised to Name Charles Woodburn Operating Chief
10:01aDJBrazil's President Limits Spending Ahead of Budget Cuts -- Update